119 related articles for article (PubMed ID: 8939279)
1. Correlation between clinical characteristics and cerebrospinal fluid neuropeptide Y levels in dementia of the Alzheimer type and frontotemporal dementia.
Minthon L; Edvinsson L; Gustafson L
Alzheimer Dis Assoc Disord; 1996; 10(4):197-203. PubMed ID: 8939279
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin and neuropeptide Y in cerebrospinal fluid: correlations with severity of disease and clinical signs in Alzheimer's disease and frontotemporal dementia.
Minthon L; Edvinsson L; Gustafson L
Dement Geriatr Cogn Disord; 1997; 8(4):232-9. PubMed ID: 9213068
[TBL] [Abstract][Full Text] [Related]
3. Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
Nilsson CL; Brinkmalm A; Minthon L; Blennow K; Ekman R
Peptides; 2001 Dec; 22(12):2105-12. PubMed ID: 11786197
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide levels in Alzheimer's disease and dementia with frontotemporal degeneration.
Minthon L; Edvinsson L; Ekman R; Gustafson L
J Neural Transm Suppl; 1990; 30():57-67. PubMed ID: 1975266
[TBL] [Abstract][Full Text] [Related]
5. Age-related increase in neuropeptide Y-like immunoreactivity in cerebrospinal fluid in women.
Taniguchi S; Yanase T; Kurimoto F; Takayanagi R; Haji M; Kurose S; Nawata H
Fukuoka Igaku Zasshi; 1994 Dec; 85(12):361-5. PubMed ID: 7883275
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid neuropeptide Y-like immunoreactivity correlates with impulsive aggression in human subjects.
Coccaro EF; Lee R; Liu T; Mathé AA
Biol Psychiatry; 2012 Dec; 72(12):997-1003. PubMed ID: 22985695
[TBL] [Abstract][Full Text] [Related]
7. Increased neuropeptide Y-like immunoreactivity in cerebrospinal fluid and plasma of human immunodeficiency virus-infected patients: relationship to HIV encephalopathy.
Malessa R; Heimbach M; Brockmeyer NH; Hengge U; Rascher W; Michel MC
J Neurol Sci; 1996 Mar; 136(1-2):154-8. PubMed ID: 8815163
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptides in cerebrospinal fluid of patients with Alzheimer's disease and dementia with frontotemporal lobe degeneration.
Edvinsson L; Minthon L; Ekman R; Gustafson L
Dementia; 1993; 4(3-4):167-71. PubMed ID: 8401787
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid somatostatin and neuropeptide Y. Concentrations in aging and in dementia of the Alzheimer type with and without extrapyramidal signs.
Atack JR; Beal MF; May C; Kaye JA; Mazurek MF; Kay AD; Rapoport SI
Arch Neurol; 1988 Mar; 45(3):269-74. PubMed ID: 2893600
[TBL] [Abstract][Full Text] [Related]
10. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia.
Engelborghs S; Vloeberghs E; Le Bastard N; Van Buggenhout M; Mariën P; Somers N; Nagels G; Pickut BA; De Deyn PP
Neurochem Int; 2008 May; 52(6):1052-60. PubMed ID: 18093695
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls.
Gjerris A; Widerlöv E; Werdelin L; Ekman R
J Psychiatry Neurosci; 1992 Mar; 17(1):23-7. PubMed ID: 1349825
[TBL] [Abstract][Full Text] [Related]
12. Quetiapine affects neuropeptide Y and corticotropin-releasing hormone in cerebrospinal fluid from schizophrenia patients: relationship to depression and anxiety symptoms and to treatment response.
Nikisch G; Baumann P; Liu T; Mathé AA
Int J Neuropsychopharmacol; 2012 Sep; 15(8):1051-61. PubMed ID: 22008251
[TBL] [Abstract][Full Text] [Related]
13. Low neuropeptide Y in cerebrospinal fluid in bipolar patients is associated with previous and prospective suicide attempts.
Sandberg JV; Jakobsson J; Pålsson E; Landén M; Mathé AA
Eur Neuropsychopharmacol; 2014 Dec; 24(12):1907-15. PubMed ID: 25453484
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y-like immunoreactivity in schizophrenia. Relationships with clinical measures.
Peters J; Van Kammen DP; Gelernter J; Yao J; Shaw D
Schizophr Res; 1990; 3(5-6):287-94. PubMed ID: 2178001
[TBL] [Abstract][Full Text] [Related]
15. Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.
Buerger K; Zinkowski R; Teipel SJ; Tapiola T; Arai H; Blennow K; Andreasen N; Hofmann-Kiefer K; DeBernardis J; Kerkman D; McCulloch C; Kohnken R; Padberg F; Pirttilä T; Schapiro MB; Rapoport SI; Möller HJ; Davies P; Hampel H
Arch Neurol; 2002 Aug; 59(8):1267-72. PubMed ID: 12164722
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y levels in central and peripheral cerebrospinal fluid in patients with intracranial disorders.
von Holst H; Rudehill A; Lundberg JM
Acta Neurochir (Wien); 1991; 112(3-4):132-5. PubMed ID: 1776515
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type.
Martignoni E; Blandini F; Petraglia F; Pacchetti C; Bono G; Nappi G
J Neural Transm Park Dis Dement Sect; 1992; 4(3):191-205. PubMed ID: 1320891
[TBL] [Abstract][Full Text] [Related]
18. Excessive release of endogenous neuropeptide Y into cerebrospinal fluid after treatment of spontaneous subarachnoid haemorrhage and its possible impact on self-reported neuropsychological performance - results of a prospective clinical pilot study on good-grade patients.
Bründl E; Proescholdt M; Schödel P; Bele S; Höhne J; Zeman F; Stoerr EM; Brawanski A; Schebesch KM
Neurol Res; 2018 Dec; 40(12):1001-1013. PubMed ID: 30213237
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid neuropeptide Y levels in major depression and reported childhood trauma.
Soleimani L; Oquendo MA; Sullivan GM; Mathé AA; Mann JJ
Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539507
[TBL] [Abstract][Full Text] [Related]
20. Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias.
Bibl M; Mollenhauer B; Lewczuk P; Esselmann H; Wolf S; Trenkwalder C; Otto M; Stiens G; Rüther E; Kornhuber J; Wiltfang J
Mol Psychiatry; 2007 Jul; 12(7):671-80. PubMed ID: 17339876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
